Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

71
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
71
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.7K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

533
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
533
FDA Approved Drugs: Changes to Approved Drugs01:26

FDA Approved Drugs: Changes to Approved Drugs

328
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
328
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

517
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
517
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices01:28

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

118
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
118

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Perioperative Interventions in Autism Spectrum Disorder: A Systematic Review of Randomized Trials.

Anesthesia and analgesia·2026
Same journal

Early Adoption of Suzetrigine After FDA Approval: Inpatient and Outpatient Practice Patterns.

Anesthesia and analgesia·2026
Same journal

Clinical Effectiveness of Acute Normovolemic Hemodilution in Cardiac Surgery: A Systematic Review and Meta-analysis.

Anesthesia and analgesia·2026
Same journal

The Next Frontier in Anesthesia Safety-From Standards to Implementation: APSF Ellison C. Pierce Lecture 2025 and WCA Harold Griffith Lecture 2026.

Anesthesia and analgesia·2026
Same journal

Multimodal Machine Learning Model Predicting Postoperative Delirium Based on Heart Rate Variability: A Prospective Observational Study.

Anesthesia and analgesia·2026
Same journal

Feasibility of Application of Artificial Intelligence in Neuroanesthesia and Neurocritical Care in Low- and Middle-Income Countries.

Anesthesia and analgesia·2026

Related Experiment Video

Updated: Mar 31, 2026

Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models
11:51

Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models

Published on: August 16, 2010

31.7K

Target-Controlled Infusions: Paths to Approval.

Paul E Dryden1

  • 1From ProMedic, Inc., Bonita Springs, Florida.

Anesthesia and Analgesia
|October 31, 2015
PubMed
Summary

Target-controlled infusion (TCI) of IV anesthetic drugs is globally approved but not in the US. This article reviews regulatory strategies for achieving TCI approval in the United States.

Area of Science:

  • Anesthesiology
  • Pharmacology
  • Regulatory Science

Background:

  • Target-controlled infusion (TCI) is an advanced method for administering intravenous anesthetic drugs.
  • TCI systems are widely approved and utilized internationally for precise drug delivery.
  • The United States currently lacks regulatory approval for TCI systems.

Purpose of the Study:

  • To examine the regulatory landscape and potential pathways for TCI system approval in the US.
  • To identify strategies that could facilitate the clearance of TCI technology within the United States.
  • To provide insights for stakeholders seeking TCI market access in the US.

Main Methods:

  • Review of existing regulatory frameworks in the US (e.g., FDA).
  • Analysis of international TCI approval processes and requirements.

More Related Videos

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

3.9K
Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats
05:09

Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats

Published on: May 16, 2025

4.4K

Related Experiment Videos

Last Updated: Mar 31, 2026

Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models
11:51

Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models

Published on: August 16, 2010

31.7K
Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

3.9K
Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats
05:09

Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats

Published on: May 16, 2025

4.4K
  • Examination of potential challenges and opportunities for TCI in the US market.

    • Main Results:

    • Identification of specific regulatory hurdles for TCI devices in the US.
    • Comparison of US requirements with those in regions where TCI is approved.
    • Outline of potential data requirements and clinical trial designs for US submission.

    Conclusions:

    • Navigating US regulatory pathways requires a thorough understanding of FDA guidelines.
    • Strategic engagement with regulatory bodies is crucial for TCI approval.
    • Successful clearance of TCI in the US could enhance anesthetic drug administration precision and patient safety.